Thursday November 26 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

BioPortfolio's Approved Drugs Database

Ibrin

Fibrinogen I-125

Download PDF containing detailed information.PDF Version

Image Results

Loading...

Companies working in the area of Ibrin from Bioportfolio's Biocorporate database :

BioPortfolio Logo
Company Name

Haemacure Corporation

Haemacure Corporation is a leader in the development and commercialization of innovative and clinically effective biological adhesives, biomaterials and surgical devices for a broad range of...
www.haemacure.com/        View full profile
Thumbshot

Capralogics Inc

In our state of art collection and processing facility Capralogics offers large scale production of liters of high quality goat plasma, defibrinated plasma, and serum...
www.capralogics.com/        View full profile
Thumbshot

Diagnostica & Analys Service AB

Haemophilia caused by Factor VIII - or Factor IX deficiency and von Willebrand disease have long been possible to diagnose, but with some difficulties for the latter. In the mid 1970's Antithrombin...
www.dia-service.se/        View full profile
Thumbshot

View more Ibrin related companies.


This page has been viewed 21 times Browse BioPortfolio's InDepth service - alphabetically: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z or by Most Publications, recently searched for, or most viewed.

Search for Ibrin across BioPortfolio, or for Ibrin Research Reports
Wikipedia excerpt, where present, licenced under the GNU Free Documentation License. Resources from the NCBI applied. Selected MeSH subject headings created and maintained by the US NLM are used in conjunction with additional keywords. 2006-2008 MeSH. Thumbshots from Thumbshots.org

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.